E-cadherin targeting antibodies (CadheRx)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameE-cadherin targeting antibodies (CadheRx)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionCadherin-1 modulators
TargetsCadherin-1
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesStony Brook University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCadheRx Therapeutics IncStony Brook University
Active IndicationsN/A
Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A
Related LinksN/A